MedPath

The Emotional Impact of Surveillance for Pancreatic Cancer

Not Applicable
Conditions
Psychological Distress
Pancreatic Cancer
Interventions
Diagnostic Test: Barratt Simplified Measure of Social Status (BSMSS)
Diagnostic Test: Global Assessment of Functioning scale (GAF)
Diagnostic Test: General Self-Efficacy Scale (GSES)
Diagnostic Test: Perceived Stress Scale (PSS)
Diagnostic Test: Coping Orientation to Problems Experienced (Brief COPE),
Diagnostic Test: Multidimensional Scale of Perceived Social Support (MSPSS)
Registration Number
NCT04024345
Lead Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Brief Summary

Due to its rarity a population screening program for pancreatic cancer is not possible. For this reason, considering background data on genetic predisposition and familiarity for this lethal tumor, efforts have been pushed to build up surveillance programs for subjects at high-risk of pancreatic cancer, due to familiarity and/or genetic predisposition. These programs are based on radiological examinations (such as MRI or endoultrasonography) and laboratory tests. However, little is known about the psychological burden of these programs. Only a handful of studies investigated, in various ways, how the participation in surveillance programs for pancreatic cancer may burden the psychological status, with a consequent possible impairment of the psychological wellbeing, and a higher risk of withdraw from the surveillance program itself. The aim of this study was to assess the psychological and emotional impact in high-risk individuals participating in a surveillance program for pancreatic cancer due to familiarity and/or to genetic predisposition, using specific psychological tools, such as multiple psychological questionnaires, investigating different functioning areas, administered by a clinical psychologist.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Being enrolled in the Institutional surveillance program for pancreatic cancer
  • Ability to understand the details and implications of a study protocol.
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Psychometric assessment groupBarratt Simplified Measure of Social Status (BSMSS)Arms to whom the psychometric assessment will be administered
Psychometric assessment groupMultidimensional Scale of Perceived Social Support (MSPSS)Arms to whom the psychometric assessment will be administered
Psychometric assessment groupGlobal Assessment of Functioning scale (GAF)Arms to whom the psychometric assessment will be administered
Psychometric assessment groupPerceived Stress Scale (PSS)Arms to whom the psychometric assessment will be administered
Psychometric assessment groupGeneral Self-Efficacy Scale (GSES)Arms to whom the psychometric assessment will be administered
Psychometric assessment groupCoping Orientation to Problems Experienced (Brief COPE),Arms to whom the psychometric assessment will be administered
Primary Outcome Measures
NameTimeMethod
Perceived Stress Scale2-year

Assessment of the perceived stress

Barratt Simplified Measure of Social Status2-years

Evaluation of cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any)

General Self-Efficacy Scale2-years

Self-report scale correlated to emotion, optimism, work

Multidimensional Scale of Perceived Social Support2-years

to explore the subject's social support system

Global Assessment of Functioning scale2-years

measure overall levels of functionality of an individual

Coping Orientation to Problems Experienced2-years

evaluation of the subject's coping style through investigation of problem-solving abilities and emotional fluctuation, as a response to stressful situations

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital of Verona

🇮🇹

Verona, VR, Italy

© Copyright 2025. All Rights Reserved by MedPath